58 related articles for article (PubMed ID: 18923400)
1. On the use of protein turnover and half-lives.
Kuhar MJ
Neuropsychopharmacology; 2009 Apr; 34(5):1172-3. PubMed ID: 18923400
[No Abstract] [Full Text] [Related]
2. Neurobiology of dopamine in schizophrenia.
Guillin O; Abi-Dargham A; Laruelle M
Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
[TBL] [Abstract][Full Text] [Related]
3. Regionally selective changes in neurotransmitter receptors in the brain of the 5-HT1B knockout mouse.
Ase AR; Reader TA; Hen R; Descarries L
J Chem Neuroanat; 2008 Jul; 35(4):356-63. PubMed ID: 18406571
[TBL] [Abstract][Full Text] [Related]
4. Subunit-specific modulation of [(3)H]MK-801 binding to NMDA receptors mediated by dopamine receptor ligands in rodent brain.
Wigestrand MB; Fonnum F; Ivar Walaas S
Neurochem Int; 2012 Jul; 61(2):266-76. PubMed ID: 22561101
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to a brain dopamine binding protein: production, specificity, and immunohistochemistry.
Hsu LL; Moroi K; Lakchaura BD; Chan T; Lin CT; Wu JY
J Neurosci Res; 1987; 17(4):417-23. PubMed ID: 3305971
[TBL] [Abstract][Full Text] [Related]
6. Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence.
Shoval G; Bar-Shira O; Zalsman G; John Mann J; Chechik G
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1123-32. PubMed ID: 24721318
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory role of methylation on the binding characteristics of dopamine receptors and transporter.
Lee ES; Chen H; Shepherd KR; Lamango NS; Soliman KF; Charlton CG
Neurosci Res; 2004 Mar; 48(3):335-44. PubMed ID: 15154679
[TBL] [Abstract][Full Text] [Related]
8. High affinity dopamine receptors (D3) in rat brain.
Titeler M; List S; Seeman P
Commun Psychopharmacol; 1979; 3(6):411-20. PubMed ID: 546589
[No Abstract] [Full Text] [Related]
9. Interaction of mephedrone with dopamine and serotonin targets in rats.
Martínez-Clemente J; Escubedo E; Pubill D; Camarasa J
Eur Neuropsychopharmacol; 2012 Mar; 22(3):231-6. PubMed ID: 21824752
[TBL] [Abstract][Full Text] [Related]
10. Radioligand binding to brain dopamine and serotonin receptors and transporters in Parkinson's disease: relation to gene polymorphisms.
Güzey C; Allard P; Brännström T; Spigset O
Int J Neurosci; 2012 Mar; 122(3):124-32. PubMed ID: 22004534
[TBL] [Abstract][Full Text] [Related]
11. Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding.
Bailey A; Metaxas A; Al-Hasani R; Keyworth HL; Forster DM; Kitchen I
Eur J Neurosci; 2010 Feb; 31(4):742-53. PubMed ID: 20384817
[TBL] [Abstract][Full Text] [Related]
12. Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.
Lin Z; Dodd CA; Filipov NM
Neurotoxicol Teratol; 2013; 39():26-35. PubMed ID: 23770127
[TBL] [Abstract][Full Text] [Related]
13. Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer.
Cherubini E; Di Napoli A; Noto A; Osman GA; Esposito MC; Mariotta S; Sellitri R; Ruco L; Cardillo G; Ciliberto G; Mancini R; Ricci A
J Cell Physiol; 2016 Feb; 231(2):345-56. PubMed ID: 26081799
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor and transporter levels are altered in the brain of Purkinje Cell Degeneration mutant mice.
Delis F; Mitsacos A; Giompres P
Neuroscience; 2004; 125(1):255-68. PubMed ID: 15051164
[TBL] [Abstract][Full Text] [Related]
15. The binding characteristics of 3H-terguride in various brain areas.
Dobrovský K; Valchár M; Dlabac A
Act Nerv Super (Praha); 1989 Dec; 31(4):274-5. PubMed ID: 2534687
[No Abstract] [Full Text] [Related]
16. Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia.
Lee FJ; Pei L; Liu F
Synapse; 2009 Aug; 63(8):710-2. PubMed ID: 19391151
[No Abstract] [Full Text] [Related]
17. Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease.
Miller S; Hill Della Puppa G; Reidling J; Marcora E; Thompson LM; Treanor J
J Huntingtons Dis; 2014; 3(4):333-41. PubMed ID: 25575954
[TBL] [Abstract][Full Text] [Related]
18. Uptake and release of neurotransmitters.
Janowsky A; Neve K; Eshleman AJ
Curr Protoc Neurosci; 2001 May; Chapter 7():Unit7.9. PubMed ID: 18428535
[TBL] [Abstract][Full Text] [Related]
19. Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD).
Nguyen M; Roth A; Kyzar EJ; Poudel MK; Wong K; Stewart AM; Kalueff AV
Neurochem Int; 2014 Jan; 66():15-26. PubMed ID: 24412511
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
